Nilotinib Pharmascience 150 mg tvrde kapsule
Name | Nilotinib Pharmascience 150 mg tvrde kapsule |
---|---|
Marketing Authorisation Number | HR-H-811247874 |
Active Substance | nilotinibklorid dihidrat |
Composition | jedna tvrda kapsula sadrži 150 mg nilotiniba (u obliku nilotinibklorid dihidrata) |
Pharmaceutical Form | Kapsula, tvrda |
Manufacturer | PharOS MT Ltd, Birzebbugia, Malta Pharos Pharmaceutical Oriented Services Ltd., Metamorfossi Attikis, Grčka |
Marketing Authorisation Holder | Pharmascience International Limited, Lampousas, 1, Nicosia, Cipar |
Marketing Authorisation Date | 27.06.2024 |
MA Period of Validity | 27.06.2029 |
Classification Number | UP/I-530-09/23-01/100 |
Registration Number | 381-12-01/70-24-09 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | L01EA03 |
SmPC | download |
PL | download |